메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

교수

주계일(Kye Il Joo) 부교수
Education
  • 2009. 12. University of Southern California, USA, 화학공학 공학박사
  • 2004. 5. University of Southern California, USA, 화학공학 공학석사
  • 2002. 2. 한양대학교 화학공학 공학사
Career
  • 2021-현재 이화여자대학교 화학신소재공학과 조교수
  • 2017-2021 포항공과대학교 화학공학과 연구조교수, 부교수
  • 2016. BoğaziçI University, Turkey 조교수(임용)
  • 2015-2016 Voyager Therapeutics, USA, 선임연구원
  • 2013-2014 ChromoLogic LLC, USA, 선임연구원
  • 2010-2013 University of Southern California, USA 박사후연구원
Research Interests
Nano-Bioengineering; Cancer Immunotherapy; Drug/Gene Delivery; Biomaterials Design; Viral Vector Engineering
Selected Publication
1. Hye Ryoung Heo, Kye Il Joo, Jeong Hyun Seo, Chang Sup Kim, and Hyung Joon Cha. “Glycan chip based on structure changeable DNA linker for on-chip biosynthesis of cancer-associated complex glycans” Nature Communications 2021, 12: 1395.

2. Jongkyeong Lim, Geunho Choi, Kye Il Joo, Hyung Joon Cha, and Joon Won Kim."Embolization of vascular malformations via in situ photocrosslinking of mechanically reinforced stable alginate microfibers using an optical-fiber-integrated flexible microfluidic device"Advanced Materials 2021, 33: 2006759.

3. Kye Il Joo, Yeonsu Jeong, Sung-Min Hwang, Mincheol Shin, Jaeyun Lee, Garima Sharma, Haena Lee, Sin-Hyeog Im, and Hyung Joon Cha. “Harnessing the bioresponsive adhesion of immuno-bioglue for enhanced local immune checkpoint blockade therapy” Biomaterials 2020, 263: 120380.

4. Eun Young Jeon, Kye Il Joo* and Hyung Joon Cha*. “Body temperature-activated protein-based injectable adhesive hydrogel incorporated with decellularized adipose extracellular matrix for tissue-specific regenerative stem cell therapy” Acta Biomaterialia 2020, 114: 244-255

5. Yeonsu Jeong, Yun Kee Jo, Bum Jin Kim, Byeongseon Yang, Kye Il Joo, and Hyung Joon Cha. “Sprayable adhesive nanotherapeutics: Mussel-protein-based nanoparticles for highly efficient locoregional cancer therapy” ACS Nano 2018, 12: 8909-8919.
Lab Overview
바이오메디컬공학 연구실에서는 Smart Biomaterial Design과 Immuno-engineering의 융합 연구를 통해서 Drug/Gene Delivery System을 개발하고 이를 Cancer Immunotherapy와 같은 바이오메티칼 분야에 적용하는 연구를 수행하고 있습니다.